BehaveNet®
Clinical Capsule™

  
Join Our Mailing List

Email:

For Email Newsletters you can trust
Movies
 		Opinion
 Facebook
 Twitter

drug: lacosamide

 
Clinical class anticonvulsant
Action  
Chemical class functionalized amino acid
CSA schedule none
DEA number  
NDC  
Routes of administration oral, parenteral
Associated with (substance-related)  

 

 disorders: none
Availability prescription
U.S. Preparations:

Vimpat® (UCB) FDA approved for treatment of:
10.28.2008 adjunctive therapy of partial-onset seizures in patients with epilepsy aged 17 years and older
U.S. Prescribing information


http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2009 BehaveNet®